Inactivating mutations, or loss, results in inactivation of the two encoding tumor suppressor genes p16 and p14. Both genes were already related to high susceptibility for CM and were found in a total of 30%–80% of familial CM [88–90]. Here, CDKN2A is linked to cutaneous mastocytosis.